Geerts J F M, van den Berg I, van Nistelrooij A M J, Lagarde S M, Wijnhoven B P L
Department of Surgery, Erasmus MC - University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands.
Department of Surgery, Catharina Hospital, Michelangelolaan 2, 5623 EJ, Eindhoven, the Netherlands.
Dis Esophagus. 2025 Jan 7;38(1). doi: 10.1093/dote/doae101.
Hospital readmission after surgery is a key quality indicator. This nationwide cohort study aimed to assess readmission rates following esophagectomy and gastrectomy for cancer and identify associated risk factors.
Data were extracted from the Dutch Upper GI Cancer Audit (DUCA) for patients with esophagogastric cancer who underwent esophagectomy or gastrectomy with curative intent between January 2011 and June 2016. Logistic regression analysis identified risk factors for 30-day readmission.
In total, 5566 patients were included. Readmission within 30 days occurred in 483 of 3488 (13.8%) patients after esophagectomy and 243 of 2078 patients (11.7%) after gastrectomy. Both minor (Clavien Dindo 1-2) and major (Clavien Dindo ≥3) postoperative complications were independent predictors of readmission after esophagectomy (OR 2.99; 95%CI 2.23-4.02; p < 0.001 and OR 5.20; 95%CI 3.82-7.09; p < 0.001). Specific complications included pulmonary (OR 1.49; 95%CI 1.20-1.85; p < 0.001), gastrointestinal (OR 2.43; 95%CI 1.94-3.05; p < 0.001), and infectious (OR 2.27; 95%CI 1.60-3.22; p < 0.001). Prolonged length of stay (pLOS) was associated with higher readmission rates in patients without complications following esophagectomy (OR 1.91 95% CI 1.19-3.07; p = 0.008), but lower rates in those with complications (OR 0.65 95% CI 0.51-0.83; p < 0.001). For gastrectomy, postoperative complications were also linked to readmission (OR 3.18; 95%CI 2.30-4.40; p < 0.001), particularly gastrointestinal (OR 2.16; 95%CI 1.40-3.32; p < 0.001), and infectious (OR 3.80; 95%CI 2.53-5.71; p < 0.001).
Readmission after esophagogastric resection is common, particularly among patients with both minor and major postoperative complications. Prolonged stay after esophagectomy impacts readmission risk differently based on the presence of complications.
手术后再次入院是一项关键的质量指标。这项全国性队列研究旨在评估食管癌和胃癌切除术后的再入院率,并确定相关风险因素。
从荷兰上消化道癌症审计(DUCA)中提取2011年1月至2016年6月间接受根治性食管癌切除术或胃癌切除术的食管胃癌患者的数据。逻辑回归分析确定了30天再入院的风险因素。
共纳入5566例患者。食管癌切除术后3488例患者中有483例(13.8%)在30天内再次入院,胃癌切除术后2078例患者中有243例(11.7%)再次入院。食管切除术后,轻微(Clavien Dindo 1-2级)和严重(Clavien Dindo≥3级)术后并发症均是再入院的独立预测因素(比值比2.99;95%置信区间2.23-4.02;p<0.001和比值比5.20;95%置信区间3.82-7.09;p<0.001)。具体并发症包括肺部(比值比1.49;95%置信区间1.20-1.85;p<0.001)、胃肠道(比值比2.43;95%置信区间1.94-3.05;p<0.001)和感染性(比值比2.27;95%置信区间1.60-3.22;p<0.001)。食管切除术后无并发症患者的住院时间延长(pLOS)与再入院率较高相关(比值比1.91,95%置信区间1.19-3.07;p=0.008),但有并发症患者的再入院率较低(比值比0.65,95%置信区间0.51-0.83;p<0.001)。对于胃癌切除术,术后并发症也与再入院有关(比值比3.18;95%置信区间2.30-4.40;p<0.001),尤其是胃肠道(比值比2.16;95%置信区间1.40-3.32;p<0.001)和感染性(比值比3.80;95%置信区间2.53-5.71;p<0.001)。
食管胃切除术后再次入院很常见,尤其是在有轻微和严重术后并发症的患者中。食管切除术后住院时间延长对再入院风险的影响因是否存在并发症而异。